1. "Larry Norton"
Formats
  1. Journal Article (409)
  2. Meeting Abstract (295)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (758)
  2. Breast Medicine Service (758)
  3. Department of Medicine (758)
  4. Solid Tumor Oncology Division (758)
  5. Survivorship Research (392)
  6. GSK Faculty (222)

More Groups

People
  1. Larry Norton (758)
  2. Clifford Hudis (293)
  3. Edi Brogi (114)
  4. Andrew Seidman (99)
  5. Sujata Patil (97)
  6. Mark Robson (89)

More People

Years
  1. 2025 (5)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (30)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (159)
  2. American Association for Cancer Research (124)
  3. Nature Publishing Group (75)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (48)

More Publishers

Results (758)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
    Meeting Abstract

    Gray, R.; Bradley, R.; Braybrooke, J.; Davies, C.; Pan, H.; Peto, R.; Bliss, J.; Cameron, D.; Mackey, J.; Del Mastro, L.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Estrogen receptor-negative breast adenomyoepitheliomas are driven by co-occurring HRAS hotspot and PI3K pathway gene mutations: A genetic and functional analysis
    Meeting Abstract

    Geyer, F. C.; Li, A.; Papanastasiou, A. D.; Smith, A.; Selenica, P.; Burke, K. A.; Edelweiss, M.; Wen, H. C.; Piscuoglio, S.; Schultheis, A. M.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Monosomy 17 in potentially curable HER2-amplified breast cancer: Prognostic and predictive impact
    Journal Article

    Page, D. B.; Wen, H.; Brogi, E.; Dure, D.; Ross, D.; Spinelli, K. J.; Patil, S.; Norton, L.; Hudis, C.; McArthur, H. L.
    Breast Cancer Research and Treatment (2018)

    Fulltext@MSK | Save
  • Breast carcinoma with 21-gene recurrence score lower than 18: Rate of locoregional recurrence in a large series with clinical follow-up
    Journal Article

    Turashvili, G.; Brogi, E.; Morrow, M.; Dickler, M.; Norton, L.; Hudis, C.; Wen, H. Y.
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene
    Journal Article

    Kim, J.; Geyer, F. C.; Martelotto, L. G.; Ng, C. K. Y.; Lim, R. S.; Selenica, P.; Li, A.; Pareja, F.; Fusco, N.; Edelweiss, M.; more...
    Journal of Pathology (2018)

    Fulltext@MSK | Save
  • An Akt3 splice variant lacking the serine 472 phosphorylation site promotes apoptosis and suppresses mammary tumorigenesis
    Journal Article

    Suyama, K.; Yao, J.; Liang, H.; Benard, O.; Loudig, O. D.; Amgalan, D.; McKimpson, W. M.; Phillips, G. R.; Segall, J.; Wang, Y.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Norton-Simon hypothesis
    Book Section

    Traina, T. A.; Norton, L.
    In Schwab, M. (Eds.) Encyclopedia of Cancer. 4th ed (2017)

    Fulltext@MSK | Save
  • Log-kill hypothesis
    Book Section

    Traina, T. A.; Norton, L.
    In Schwab, M. (Eds.) Encyclopedia of Cancer. 4th ed (2017)

    Fulltext@MSK | Save
  • Longer follow-up on cardiac safety and distant disease free survival of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab in patients with early-stage HER2-positive breast cancer
    Meeting Abstract

    Wang, R.; Yu, A. F.; Steingart, R.; Patil, S.; Baselga, J.; Norton, L.; Hudis, C.; Dang, C. T.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save